Literature DB >> 14736736

Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.

Alon Chen1, Amy Blount, Joan Vaughan, Bhawanjit Brar, Wylie Vale.   

Abstract

Peptides encoded by the Urocortin (Ucn) II gene, also known as stresscopin-related peptide, were recently identified as new members of the corticotropin-releasing factor (CRF) family. Ucn II is a specific ligand for the type 2 CRF receptor (CRFR). We have demonstrated the peripheral distribution of mouse Ucn (mUcn) II transcripts by using specific mUcn II ribonuclease protection assays, RT-PCR, Southern hybridization, and DNA sequencing. Although Ucn II mRNA is widely expressed in a variety of peripheral tissues, we found it to be most highly expressed in the skin and skeletal muscle tissues. Using a specific RIA for mUcn II, we detected Ucn II-like immunoreactivity (ir) in acid extracts of mouse brain, muscle, and skin. Immunohistochemical studies revealed Ucn II-like ir in both skin epidermis and adnexal structures and in the skeletal muscle myocytes. Ucn II mRNA and ir were also observed in neonatal skeletal muscle cultures in which Ucn II was localized to the myotube. We found a significant increase in Ucn II mRNA levels in the skin, but not in skeletal muscle, of both CRFR1- and CRFR2-null mice compared with their wild-type littermates. We showed that administration of dexamethasone to mice resulted in a decrease of Ucn II mRNA levels in the back skin region 12 h after ip injections. Removal of the adrenal gland significantly increased the levels of Ucn II mRNA in the skin, and the levels were reduced back to normal levels after corticosterone replacement. Further examination of the distribution and regulation of CRFR2 and its specific ligand Ucn II in the skin and skeletal muscle tissues may reveal the manner by which the CRFR2 pathway is involved in the physiological responses to stress in these tissues and in other pathophysiologies of the skin and muscle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736736     DOI: 10.1210/en.2003-1570

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.

Authors:  Hongxia Chao; Haochen Li; Rebecca Grande; Vitor Lira; Zhen Yan; Thurl E Harris; Chien Li
Journal:  Mol Endocrinol       Date:  2015-04-15

Review 2.  Corticotropin releasing hormone and the skin.

Authors:  Andrzej Slominski; Blazej Zbytek; Michal Zmijewski; Radomir M Slominski; Sobia Kauser; Jacobo Wortsman; Desmond J Tobin
Journal:  Front Biosci       Date:  2006-09-01

3.  The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.

Authors:  B Lu; Y Diz-Chaves; D Markovic; A Contarino; L Penicaud; F Fanelli; S Clark; H Lehnert; D Cota; D K Grammatopoulos; A Tabarin
Journal:  Int J Obes (Lond)       Date:  2014-09-05       Impact factor: 5.095

4.  Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.

Authors:  S Vincent Wu; Pu-qing Yuan; Lixin Wang; Yen L Peng; Chih-Yen Chen; Yvette Taché
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

5.  Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle.

Authors:  Alon Chen; Bhawanjit Brar; Cheol Soo Choi; David Rousso; Joan Vaughan; Yael Kuperman; Shee Ne Kim; Cindy Donaldson; Sean M Smith; Pauline Jamieson; Chien Li; Tim R Nagy; Gerald I Shulman; Kuo-Fen Lee; Wylie Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

6.  Corticotropin-releasing factor receptor 2 mediates sex-specific cellular stress responses.

Authors:  Eric Kubat; Shilpi Mahajan; Min Liao; Larry Ackerman; Peter T Ohara; Eileen F Grady; Aditi Bhargava
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

7.  Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

Authors:  E M Fekete; Y Zhao; A Szücs; V Sabino; P Cottone; J Rivier; W W Vale; G F Koob; E P Zorrilla
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

8.  Differential actions of urocortins on neurons of the myenteric division of the enteric nervous system in guinea pig distal colon.

Authors:  Sumei Liu; W Ren; M-H Qu; G A Bishop; G-D Wang; X-Y Wang; Y Xia; J D Wood
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

9.  Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products.

Authors:  Joan M Vaughan; Cynthia J Donaldson; Wolfgang H Fischer; Marilyn H Perrin; Jean E Rivier; Paul E Sawchenko; Wylie W Vale
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

10.  Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis.

Authors:  Chien Li; Peilin Chen; Joan Vaughan; Kuo-Fen Lee; Wylie Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.